The appearance of stars at the Oscars 2026 has sparked debate over Hollywood's growing reliance on GLP-1 weight-loss drugs, as several actors appeared dramatically thinner. Experts warn that off-label use carry serious side effects, including gastrointestinal issues and muscle loss. Doctors also caution that the rising demand could exacerbate shortages for diabetes patients who rely on the drug.